Improved oral delivery of tilianin through lipid-polymer hybrid nanoparticles to enhance bioavailability.
Sign Up to like & getrecommendations! Published in 2019 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2019.09.004
Abstract: Tilianin (TIL) may prevent and treat myocardial ischemia reperfusion injuries. However, its oral administration is hampered by its low bioavailability. The present study aimed to formulate lipid-polymer hybrid nanoparticles (LPHNs) as carriers for the sustained… read more here.
Keywords: til lphns; til; lipid polymer; bioavailability ... See more keywords